New study tracks COVID-19 drug safety in pregnancy
NCT ID NCT05013632
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 26 times
Summary
This study follows 2,000 pregnant women who took certain COVID-19 drugs (monoclonal antibodies or antivirals) to see how these medicines affect pregnancy and baby health. Researchers compare their outcomes with those of pregnant women who did not receive these treatments. The goal is to gather safety information, not to test a new cure or treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pregistry
RECRUITINGLos Angeles, California, 90045, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.